Suppr超能文献

左心室辅助装置治疗后的心脏恢复:完全装置取出术,包括心室补片成形术的经验。

Cardiac recovery following left ventricular assist device therapy: experience of complete device explantation including ventricular patch plasty.

机构信息

Clinic for Thoracic and Cardiovascular Surgery, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.

出版信息

Eur J Cardiothorac Surg. 2021 Apr 29;59(4):855-862. doi: 10.1093/ejcts/ezaa461.

Abstract

OBJECTIVES

Myocardial recovery is a rare phenomenon in left ventricular assist device (LVAD) therapy. Surgical LVAD removal is associated with the risk of cardiac failure, and the individual evaluation of sufficient myocardial recovery is crucial. Thus, complete device explantation is not consistently performed to minimize perioperative risk. However, the remaining ventricular assist device components bear significant risks of infection or thrombosis. Therefore, we developed this study to evaluate a complete LVAD explantation protocol.

METHODS

All patients in our institution who had an LVAD explanted were enrolled in the study. Explant surgery involved removal of the driveline, pump housing, sewing ring and outflow graft. The ventricular wall was reconstructed by double patch plasty. Our analysis focused on surgical and postoperative outcome parameters, including all-cause mortality and major adverse cardiac and cerebrovascular events.

RESULTS

A total of 12 patients (HVAD, n = 5; HeartMate II, n = 3; HeartMate 3, n = 4) had myocardial recovery and qualified for our LVAD explantation study protocol [median age: 40 years, interquartile range (IQR) 33-52 years; 50% men]. Primary heart failure aetiology: myocarditis (n = 5), dilated cardiomyopathy (n = 4), toxic cardiomyopathy (n = 2) and valvular heart failure (n = 1). The median average duration on LVAD was 10 months (25-75%: IQR 8.5-30 months). The median left ventricular ejection fraction was 15% (IQR 13-18%) at LVAD implantation and 50% (IQR 45-50%) before LVAD explantation (P = 0.0025).The 30-day survival was 100%. The 1-year survival was 91.7%. All patients were discharged after a median 13 days (IQR 10-18 days) postoperatively. No patient had major adverse cardiac and cerebrovascular events. The New York Heart Association functional class remained consistent during the follow-up period (median New York Heart Association functional class: II, IQR II-II class) including preservation of ventricular function.

CONCLUSIONS

Complete LVAD explantation with ventricular patch plasty is feasible and has consistent long-term results.

摘要

目的

左心室辅助装置(LVAD)治疗中,心肌恢复是一种罕见现象。外科 LVAD 移除与心力衰竭风险相关,因此充分评估心肌恢复至关重要。因此,并非始终进行完全装置取出以将围手术期风险降至最低。然而,LVAD 的剩余部分存在严重的感染或血栓形成风险。因此,我们制定了这项研究以评估完整的 LVAD 取出方案。

方法

我们机构中所有进行 LVAD 取出的患者均被纳入研究。取出手术包括移去输送系统、泵壳、缝合环和流出道移植物。心室壁通过双补丁成形术进行重建。我们的分析重点是手术和术后结果参数,包括全因死亡率和主要心脏和脑血管不良事件。

结果

共有 12 名患者(HVAD,n=5;HeartMate II,n=3;HeartMate 3,n=4)出现心肌恢复并符合我们的 LVAD 取出研究方案标准[中位年龄:40 岁,四分位距(IQR)33-52 岁;50%为男性]。原发性心力衰竭病因:心肌炎(n=5)、扩张型心肌病(n=4)、中毒性心肌病(n=2)和瓣膜性心力衰竭(n=1)。LVAD 平均使用时间中位数为 10 个月(25-75%:IQR 8.5-30 个月)。LVAD 植入时左心室射血分数中位数为 15%(IQR 13-18%),LVAD 取出前为 50%(IQR 45-50%)(P=0.0025)。30 天生存率为 100%。1 年生存率为 91.7%。所有患者术后中位住院时间为 13 天(IQR 10-18 天)。无患者发生主要心脏和脑血管不良事件。在随访期间纽约心脏协会心功能分级保持一致(中位数纽约心脏协会心功能分级:II 级,IQR II-II 级),包括心室功能的维持。

结论

完全 LVAD 取出联合心室补丁成形术是可行的,具有一致的长期结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验